Cailin Collins

Dr. Collins is an Assistant Professor in the Division of Hematology at the University of Colorado Anschutz Medical Campus, where she leads a translational research program studying the mechanisms of preleukemic transformation in myeloid malignancies. Following her undergraduate studies at Williams College, Dr. Collins received her MD/PhD from the University of Michigan, where she worked with Dr. Jay Hess studying the role of collaborator proteins in HOXA9-mediated leukemic transformation. She then completed residency and fellowship training in Hematology/Oncology at Stanford, where she completed her postdoctoral research training in Dr. Ravi Majeti’s lab. Her current research focuses on understanding how combinations of genetic mutations alter hematopoietic stem cell function and drive progression from preleukemic states to aggressive myeloid malignancies, such as AML and CMML. Using engineered human stem cell models and primary patient samples, her work aims to identify mechanisms of leukemic transformation and therapeutic vulnerabilities that can be targeted early in disease evolution.